Continuous support

20 November 2018
We provide affordable and reliable programmes of support to commissioners to keep their knowledge up to date and help them to develop the expertise they need in the ever-changing landscape of health policy and practice.
 
Why an annual contract?
 
Many NHS England offices and CCGs have annual contracts with PCC to:
 
  • Ensure that they are working with the latest information
  • Access client-only services such as the PCC helpdesk
  • Mitigate the risk of potentially costly mistakes 
  • Avoid the costs of consulting lawyers except where absolutely necessary
  • Provide the bespoke support their individual circumstances require
  • Reduce the cost and hassle of writing business cases every time they need support.
 
We understand the challenges you face: Lack of resources – primary care teams have always been overstretched but never more so than today. Commissioning budgets are also under pressure forcing commissioners to make the best possible use of the resources they have to maintain quality of care for patients. 
 
Continual change – legislation, regulation and policy never stand still. Staying up to date is only part of the challenge. Commissioners are interested to know how their own roles are changing and what skills they will need to become effective partners in the strategic leadership of the health and care system.
 
The integrated care agenda – just as service delivery now reflects the need to break down traditional distinctions between primary and secondary care, community services and social care, so commissioning also needs to change.
 
Increasing risk – new contracting models and ways of working present huge opportunities but may also incur higher risks including increased risk of legal challenge, thwarted plans and reputational damage.  
 
Collaboration and engagement – history shows that change cannot be imposed but only succeeds when there is a coalition of the willing. Working across traditional organisational barriers with the full range of stakeholders requires strong leadership that is also sensitive to the needs of others. Moving from the command and control model of the past to a collaborative model fit for the future requires a seismic shift in attitudes and skills.
 
How we help
 
We are acknowledged experts in primary care contracting and commissioning. Our adviser team provides highly-regarded workshops covering the contracting routes available to commissioners across the four main primary care professional groups. 
 
An annual support contract includes:
 
  • Access to our programme of national events
  • A range of e-learning courses
  • Unlimited access to the adviser helpdesk
  • A choice of local training and development workshops
  • The latest news and analysis to keep your knowledge current.
 
Our online helpdesk provides rapid answers to queries from commissioners struggling to make sense of the many grey areas in the regulations. Our advisers can draw on an extensive database of experience from other areas – and if they can’t answer the question directly, they know where to go for an authoritative opinion.
 
Access to our national event programme and local workshops will keep your knowledge and technical skills up to date. Our service has evolved and broadened to support the development of the other softer skills you and your team needs. A growing portfolio of personal and team development programmes, events and e-learning courses enable you to build the personal and team capabilities necessary to respond to – and lead – change.  
 
Find out more about annual contracts for your organisation or contact enquiries@pcc-cic.org.uk
 
An annual contract is not the only way to work with PCC. You can also choose pay-as-you-go access to our events and e-learning. We also provide local workshops and project support tailored to your individual needs.
Continuous support

Latest News

New code of conduct for AI systems

20 February 2019

The Department of Health and Social Care has issued a code of conduct for artificial intelligence (AI) and other data-driven technologies will ensure that only the best and safest systems are used by the NHS.

The code encourages technology companies to meet a gold-standard set of principles to protect patient data to the highest standards. It has been drawn up with the help of industry, academics and patient groups.

The aim is to make it easier for suppliers to develop technologies that tackle some of the biggest issues in healthcare, such as dementia, obesity and cancer. It will also help health and care providers choose safe, effective and secure technology to improve the services they provide.

Read More

More on GMS contract changes 2019/20

20 February 2019

NHS England has written to directors of primary care and senior CCG managers with further details of changes to the GMS contract for 2019/20. It includes notification of the one-off payment for indemnity inflation, changes to the value of QOF, global sum and out-of-hours payments, and the £1.761 per weighted patient for signing up to the forthcoming network contract directed enhanced service (DES).

Read More

Tobacco control assessment tools

19 February 2019

Self-assessment tools from Public Health England help local public health bodies to scrutinise their tobacco control work.

Read More

EU advice notice on falsified medicines directive

19 February 2019

The Safety Features Delegated Regulation, part of the EU Falsified Medicines Directive (FMD), will apply in the UK from 9 February 2019. Healthcare institutions are required to verify and decommission medicines supplied or administered directly to patients. All GP practices “personally administer” some medications and the decommissioning of these elements are covered by the GPIT operating model arrangements and centrally funded. According to the Medicines and Healthcare products Regulatory Agency (MHRA) FMD requirements would need to removed from law in the event of a no deal EU exit as we would no longer have access to the EU system. FMD preparations need to continue “with appropriate caution” given the possibility of a no deal scenario, the MHRA says.

Read More

NICE draft guidance recommends pertuzumab for early treatment of breast cancer

19 February 2019

NICE has published guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.

Read More